Solutions Line of Credit (VelocityLOC)Invoice Purchase (VelocityFlex)Short-Term Advance (VelocityStretch)Term Loans (VelocityTerm)
Industries All industries Staffing & Workforce SolutionsTransportation & LogisticsIT Services & ConsultingManufacturingPharmaceutical & Life SciencesBusiness Services & BPOFacility ServicesOil & Gas Services
Case Studies Insights
Company About InterNexPartnersFAQContact
Log in Client loginApplicant loginPartner login
Apply for capital(646) 849-1800

Working Capital for a Specialty Pharmaceutical Manufacturer in Growth Mode

$3.5MMNon-Notified Revolving Line of Credit

A specialty pharmaceutical developer and manufacturer in rapid growth mode needed working capital to fund product development, commercialization and expanding operations in a highly capital-intensive industry.

Client snapshot

$3.5MM facility

Non-notified
Industry
Pharmaceutical & Life Sciences
Location
Bridgewater, New Jersey
Facility
$3.5MM Non-Notified Revolving Line of Credit

Client name withheld. Facility limit at closing.

The challenge

Product development, scaling operations and rising working capital needs all competed for the same cash as the company moved new products from development to revenue.

The InterNex Capital solution

InterNex Capital provided a $3.5MM non-notified revolving line of credit that delivered immediate liquidity, supported new product launches and gave the company the flexibility to scale as revenue growth accelerated.

The company was integrated into Velocity, our cloud-based AR management platform.

  • $3.5MM non-notified revolving line of credit
  • Integration into Velocity, our cloud-based AR management platform
  • Flexibility to scale as revenue grows

The results

  • Working capital for development-to-revenue support
  • Flexibility to accommodate revenue growth
  • Non-intrusive structure for the client's customer relationships

A smarter alternative

Pharmaceutical and life sciences companies often sell to large, creditworthy distributors and health systems. Those receivables can support a line of credit that funds the next launch without diluting ownership.

Frequently asked questions

Can a pharmaceutical company finance product launches with receivables?

Yes. Receivables owed by creditworthy commercial customers can support a revolving line that funds development and commercialization costs.

Will distributors and customers be notified?

No. The facility is non-notified.

More case studies

Manufacturing Chicago, Illinois

$6MM

Non-Notified Revolving Line of Credit

Flexible Working Capital for a Custom Payment Card Manufacturer

A custom payment card manufacturer serving financial institutions and major enterprise clients needed a more flexible working capital solution to support seasonal demand, production cycles and future growth.

Facility Services Allentown, Pennsylvania

$9MM

Non-Notified Revolving Line of Credit

Scalable Working Capital for a Multi-State Facility Maintenance Provider

A multi-state facility maintenance provider serving large commercial and logistics customers needed scalable working capital to support rapid growth, seasonal demand and expanding operations across 15 states.

Transportation & Logistics Lehi, Utah

$7MM

Non-Notified Revolving Line of Credit

Scalable Working Capital for a Rapidly Expanding 3PL

A fast-growing 3PL spun off from an established trucking and logistics company was too new for its bank, and its largest customers would not work with a factor. InterNex provided…

Talk to a lender

Need a facility like this one?

Tell us about your business and your receivables. A senior lender will come back to you within one to two business days.

  • A proposal within 48 hours of a complete file
  • No obligation and no impact on your customers
  • Speak directly with a senior lender, not a call center
(646) 849-1800 600 Mamaroneck Ave, Suite 400, Harrison, NY 10528
What is the nature of your enquiry?